Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 12:11:395-403.
doi: 10.2147/IJWH.S193905. eCollection 2019.

Engaging study participants in interpreting results: lessons from the TRIO study in Kenya and South Africa

Kawango Agot  1 , Alexandra M Minnis  2 , Kgahlisho Manenzhe  3 , Erica N Browne  2 , Khatija Ahmed  3 , Timothy Okello  1 , Ariane van der Straten  2
Affiliations

Engaging study participants in interpreting results: lessons from the TRIO study in Kenya and South Africa

Kawango Agot et al. Int J Womens Health. .

Abstract

Background: Women account for 56% of new HIV infections in sub-Saharan Africa. Multipurpose Prevention Technologies (MPTs) are promising interventions because they combine HIV prevention with a less stigmatizing indication, such as pregnancy. We conducted a study with three placebo-only MPT products in Kisumu, Kenya and Soshanguve, South Africa, to assess preferences for attributes of tablets, vaginal rings and injectable products for dual prevention of HIV and pregnancy (TRIO Study). Here, we present former TRIO participants' views on the study results. Methods: After study completion in 2017, we held five dissemination sessions (two in Kisumu and three in Soshanguve) and five one-on-one sharing sessions in Soshanguve. Key results were discussed, with a focus on why some study products were more popular than others, which findings were surprising and why some women changed products over time. A thematic approach was used for analysis. Results: All 277 TRIO participants were telephoned, 168 (60.6%) were reached and 117 (42.2%) attended the dissemination sessions: 71 in Kisumu and 46 in Soshanguve. Participants were engaged and interested in the TRIO findings and willingly shared their perspectives and views candidly. Ease of use, discretion and familiarity were highlighted as drivers of product choice whereas novelty presented a challenge. In explaining the discrepancy between preference ratings and choices, participants cited features such as tablets being easy to explain to a partner or to discontinue. In explaining why 20% of participants switched products after practical experience, issues related to relationships with partners and product attributes perceived as unfavorable were paramount. Conclusion: The dissemination sessions provided an important forum for study participants to interrogate and explain the results to minimize possible misinterpretation. This exercise helped give context to the results, ensured correct lessons were derived from those results and increased credibility of the findings reported by the investigators.

Keywords: MPT products; biomedical HIV prevention; community-engaged research; end-user research.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
TRIO study design. Abbreviation: TRIO, Tablets, Ring, Injections as Options.
See this image and copyright information in PMC

References

    1. UNAIDS. UNAIDS DATA; 2017. Available from: http://www.unaids.org/en/resources/documents/2017/2017_data_book. Accessed April 11, 2018.
    1. Joint United Nations Programme on HIV/AIDS, Global AIDS Update, 2016. Available from: https://www.who.int/hiv/pub/arv/global-AIDS-update-2016_en.pdf?ua=1. Accessed April 11, 2018.
    1. Quarraisha AK, Ayesha BK, Kerry L, et al. Prevalence of HIV, HSV-2 and pregnancy amongst high school students in rural KwaZulu-Natal: a bio-behavioral cross-sectional survey. Sex Transm Infect. 2014;90(8):620–626. doi:10.1136/sextrans-2014-051548 - DOI - PMC - PubMed
    1. UNAIDS. UNAIDS Strategy 2016-2021. Available from: http://www.unaids.org/en/resources/documents/2015/UNAIDS_PCB37_15-18. Accessed April 11, 2018.
    1. Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411–422. doi:10.1056/NEJMoa1202614 - DOI - PMC - PubMed

LinkOut - more resources